p62 (SQSTM1)

The p62/Sequestosome 1 (p62, SQSTM1) protein is a scaffold protein that binds polyubiquitin chains and forms a cytoplasmic “sequestosome” where ubiquitinated, mis-folded, or non-functional proteins are stored for autophagic degradation. Tumor cells often utilize autophagy for survival in low nutrient and hypoxic conditions or in response to cancer treatments. Inhibition of p62 action may enhance chemotherapies by disrupting the pro-survival signaling cascades that work to maintain cell integrity and limit apoptosis. p62 functions in concert with tumor necrosis factor receptor associated factor 6 to mediate activation of nuclear factor kappa-B signaling pathway in response to upstream signals involving atypical protein kinase C. Overexpression or dysregulation of p62 interactions can result in large cytoplasmic aggregates including those found in aggregation diseases affecting the brain and liver. These include Lewy bodies in Parkinson’s disease, neurofibrillary tangles in Alzheimer’s disease, toxic aggregates in hepatocellular carcinomas, and amyloid deposits present in wide variety of clinical diseases. Therefore, proper p62-mediated regulation of intracellular protein processing is essential to maintain cellular homeostasis and limit the cytotoxic and pro-inflammatory cellular environments that augment the improper protein folding and aggregation often prevalent in degenerative diseases.

 

p62 (SQSTM1) Singleplex Products

Our p62 (SQSTM1) immunoassays provide fast, accurate, reproducible, and highly sensitive measurements of p62 (SQSTM1). MSD’s MULTI-ARRAY technology uses simple protocols, requires minimal sample, and quantifies analyte concentration over a wide dynamic range.

 

View All
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters